FDA Inspection 1290334 — SGS Institut Fresenius Berlin GmbH & Co. KG

SGS Institut Fresenius Berlin GmbH & Co. KG — FEI 3004908885

The FDA completed an inspection of SGS Institut Fresenius Berlin GmbH & Co. KG on November 23, 2023 in Berlin. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 23, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Berlin (Germany)

Additional Details

Mutual Recognition Agreement (MRA)